Induction of cyclo-oxygenase-2 mRNA by prostaglandin E2 in human prostatic carcinoma cells
1997
Prostaglandin E2 and Its Role in Prostate Cancer Cell Growth
publication
Evidence: moderate
Author Information
Author(s): RR Tjandrawinata, R Dahiya, M Hughes-Fulford
Primary Institution: University of California, San Francisco
Hypothesis
The study investigates the effects of exogenous dimethylprostaglandin E2 (dmPGE2) on prostate cancer cell growth and COX-2 expression.
Conclusion
The study concludes that dmPGE2 increases prostate cancer cell growth and COX-2 mRNA levels, suggesting a role for PGE2 in maintaining cancer cell proliferation.
Supporting Evidence
- Administration of dmPGE2 significantly increased cellular proliferation in PC-3 cells.
- DmPGE2 also increased COX-2 mRNA levels in a time- and dose-dependent manner.
- Flurbiprofen inhibited the up-regulation of COX-2 mRNA and PC-3 cell growth.
Takeaway
This study shows that a substance called PGE2 helps prostate cancer cells grow, and stopping it can slow down their growth.
Methodology
The study used human prostatic carcinoma PC-3 cells and measured cell growth, DNA content, and COX-2 mRNA levels in response to dmPGE2 treatment.
Statistical Information
P-Value
0.0008
Statistical Significance
p<0.05
Want to read the original?
Access the complete publication on the publisher's website